Sparking Potential, Revealing Infant Neurocognitive Traits
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT07390136
- Status
- Recruiting
Conditions
- Healthy Participants
- Perinatal Brain Injury
Eligibility Criteria
- Sex
- ALL
- Age
- 3 Months - 24 Months
- Healthy Volunteers
- Accepted
Study Details
This research focuses on the long-term cognitive development of children, including healthy infants and those who had a perinatal brain injury. As part of this research study, children complete virtual game and assessments. Parents will be asked to fill out questionnaires about their child's behavior and stress in the home. All study visits will take place online via Zoom.
Key Dates
- Start date
- Jul 30, 2024
- Status verified
- Feb 2026
- Primary completion
- Jul 31, 2030
- Completion
- Jul 31, 2030
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Children with perinatal brain injuriesChildren ages 6 months (may be enrolled prior to 6 months) - 24 months who are diagnosed with 1) hypoxic- ischemic encephalopathy, 2) cerebral palsy, and/or 3) were born premature at less than 28 weeks gestational age.
- Arm: Healthy ChildrenChildren ages 6 months (may be enrolled prior to 6 months) - 24 months of age with no prior history of a brain and/or cardiac illness early in life.
Primary Outcome Measure
Infant Attention Task (IAT) [ Time Frame: Assessed at the 12,18, and 24-month time points ]
Central Contacts
- Melisa Carrasco McCaul, MD, PhD608-577-2415
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Wisconsin-Madison School of Medicine and Public Health | Madison | Wisconsin | 53726 | Melisa Carrasco McCaul, MD, PhD 608-577-2415 |
Find similar trials in Madison, WI
Related Studies
- Temporal Interference for Thalamocortical Activity and Network ModulationPHASE1 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Biomarkers Study in Infants With Prior Neonatal Brain InjuryRecruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous DosePHASE1 · Recruiting · Amgen · Daytona Beach, Florida
- Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During SleepRecruiting · University of Wisconsin, Madison · Madison, Wisconsin